Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $51.00 and last traded at $51.00, with a volume of 10 shares changing hands. The stock had previously closed at $54.00.
Basilea Pharmaceutica Trading Down 5.6 %
The firm has a fifty day moving average of $53.23 and a 200 day moving average of $52.86. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70.
Basilea Pharmaceutica Company Profile
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
- Five stocks we like better than Basilea Pharmaceutica
- Financial Services Stocks Investing
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- What Does a Stock Split Mean?
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
